Home/Pipeline/Oncology Vaccine Program

Oncology Vaccine Program

Oncology (unspecified)

Pre-clinicalActive

Key Facts

Indication

Oncology (unspecified)

Phase

Pre-clinical

Status

Active

Company

CHAIN Biotech

About CHAIN Biotech

CHAIN Biotech is a private, pre-clinical stage biotech leveraging its proprietary Clostridium Assisted Drug Delivery (CADD™) platform to create orally administered vaccines and immuno-therapies. The platform utilizes engineered, non-pathogenic Clostridium butyricum spores to deliver therapeutic payloads directly to the lower GI tract, aiming to overcome traditional oral delivery challenges. The company is initially focused on anti-infective and anti-cancer vaccines, has secured seed funding, and is building strategic collaborations, such as one with the German Cancer Research Center (DKFZ), to advance its pipeline.

View full company profile

Therapeutic Areas

Oncology Infectious Diseases

Other Oncology (unspecified) Drugs

Drug	Company	Phase	Status
ARX305	NovoCodex Biopharmaceuticals	Phase 1	Active
ARX788	NovoCodex Biopharmaceuticals	Phase 1	Active
Cancer Immunotherapy Nanotherapeutic	Flashpoint Therapeutics	Phase 1	Active
GRWD5769	Greywolf Therapeutics	Phase 1/2	Active
Platform-derived Program(s)	Immuto Scientific	Discovery/Pre-clinical	Active
MBT Oncology Program	Ionic Pharmaceuticals	Pre-clinical	Active
ISB 2301	Ichnos Glenmark Innovation	Preclinical	Active
GRC 65327	Ichnos Glenmark Innovation	Preclinical	Active
Platform-Derived Pipeline	Phinomics	Discovery/Pre-clinical	Active
Lead Small-Molecule Inhibitor	Eris Biotech	Pre-clinical	Active
Orotecan™	Edison Oncology	Phase 1/2a	Active
DDX3 Inhibitor (Oncology)	Lead Discovery Siena	Discovery	Active